Cellogen Therapeutics
PrivateLast Round
VC Round
May 18, 2026
Momentum Score
25 /100
Company Overview
Cellogen Therapeutics is a biotechnology company that develops CAR-T cell-based therapies for the treatment of cancer and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellogen Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Cellogen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 18, 2026 |
Cellogen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kotak Alternate Asset Managers | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Grew 16% QoQ, from 19 to 22 employees.
- May 18, 2026
$2.3M round led by Kotak Alternate Asset Managers.
Cellogen Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellogen Therapeutics's valuation, stock price, and market status.
